Production (Stage)
Comprehensive Healthcare Systems, Inc.
CHS.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.73% | -7.97% | -7.52% | -13.28% | -10.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.73% | -7.97% | -7.52% | -13.28% | -10.90% |
| Cost of Revenue | -35.90% | -18.57% | -2.58% | 3.91% | -7.78% |
| Gross Profit | 77.13% | 10.91% | -16.21% | -37.73% | -17.35% |
| SG&A Expenses | -38.78% | -79.50% | -70.27% | -55.55% | -41.41% |
| Depreciation & Amortization | -12.02% | 106.80% | 1.95% | 169.09% | 133.03% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.57% | -52.04% | -46.19% | -33.39% | -24.54% |
| Operating Income | 70.67% | 86.83% | 74.74% | 50.56% | 35.96% |
| Income Before Tax | 83.11% | 97.65% | 69.63% | 44.41% | 29.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 83.11% | 97.65% | 69.63% | 44.41% | 29.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 83.11% | 97.65% | 69.63% | 44.41% | 29.58% |
| EBIT | 70.67% | 86.83% | 74.74% | 50.56% | 35.96% |
| EBITDA | 69.29% | 86.56% | 74.47% | 54.15% | 39.05% |
| EPS Basic | 83.33% | 98.10% | 77.89% | 63.56% | 57.20% |
| Normalized Basic EPS | 67.75% | 85.89% | 78.33% | 66.18% | 59.99% |
| EPS Diluted | 83.33% | 98.10% | 77.89% | 63.56% | 57.20% |
| Normalized Diluted EPS | 67.75% | 85.89% | 78.33% | 66.18% | 59.99% |
| Average Basic Shares Outstanding | 0.64% | 10.77% | 26.00% | 46.40% | 68.58% |
| Average Diluted Shares Outstanding | 0.64% | 10.77% | 26.00% | 46.40% | 68.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |